Literature DB >> 8882003

Chemoenzymatic synthesis of D(-)phenylglycine using hydantoinase of Pseudomonas desmolyticum resting cells.

D V Gokhale1, K B Bastawde, S G Patil, U R Kalkote, R R Joshi, R A Joshi, T Ravindranathan, B G Gaikwad, V V Jogdand, S Nene.   

Abstract

We screened 125 Pseudomonas strains from our culture collection for the production of hydantoinase activity using DL-phenylhydantoin as a substrate. Pseudomonas desmolyticum NCIM 2112 was found to be the best hydantoinase (dihydropyrimidinase E.C. 3.5.2.2) producer. The enzymatic reactions were carried out using 18-20-h grown cells in nutrient broth and 5-phenylhydantoin as the substrate. Optimization studies for the biotransformation reaction were performed to increase product yield. The optimum pH and temperature for D(-)N-carbamoylphenylglycine production were 9.5 and 30 degrees C, respectively. Biotransformation under these alkaline conditions allowed the complete conversion of 27.0 g l-1 of DL-phenylhydantoin to 26.5 g l-1 of N-carbamoylphenylglycine within 24 h, with a molar yield of 90%. The hydantoinase involved in this biotransformation process was strictly D-stereospecific, because the product isolated was pure D(-)N-carbamoylphenylglycine. This pure product was further chemically converted to D(-)phenylglycine using nitrous acid with an 80% chemical yield. Thus, the overall conversion efficiency of DL-5-phenylhydantoin to D(-)phenylglycine was found to be 65-68%.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882003     DOI: 10.1016/0141-0229(95)00127-1

Source DB:  PubMed          Journal:  Enzyme Microb Technol        ISSN: 0141-0229            Impact factor:   3.493


  1 in total

1.  Process parameter optimization for hydantoinase-mediated synthesis of optically pure carbamoyl amino acids of industrial value using Pseudomonas aeruginosa resting cells.

Authors:  Anupama S Engineer; Anita P Dhakephalkar; Raghavendra P Gaikaiwari; Prashant K Dhakephalkar
Journal:  J Ind Microbiol Biotechnol       Date:  2013-09-25       Impact factor: 3.346

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.